Geneva, July 14 -- International Clinical Trials Registry received information related to the study (ISRCTN11329248) titled 'Phase I Trial: Quotient Code QSC303217' on July 1.
Study Type: Interventional
Study Design:
Two-part single-centre mass balance recovery and food effect study in healthy volunteers (Other)
Primary Sponsor: Aardvark Therapeutics, Inc.
Condition:
The sponsor has confirmed that the trial meets the criteria for deferral of publication of the full details of the trial. Full details will be added to the study record within 30 months after the trial has ended.
Other
Intervention:
The sponsor has confirmed that the trial meets the criteria for deferral of publication of the full details of the trial. Full detail...